The usefulness of nutrition and prehabilitation therapy during neoadjuvant chemotherapy for resectable pancreatic cancer:A prospective observational study
Not Applicable
Recruiting
- Conditions
- resectable pancreatic cancer
- Registration Number
- JPRN-UMIN000050927
- Lead Sponsor
- Department of Gastroenterology and Hepatology, Kurashiki Central Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 120
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients with postoperative recurrence of pancreatic cancer 2) Patients who are unable to undergo surgery after neoadjuvant chemotherapy 3) Patients who are judged to be ineligible for this study by the investigator
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method comparing Nutritional index(Body weight,BMI:body mass index,albumin,PNI:prognostic nutritional index,GPS:glasgow prognostic score,modifiedGPS,NLR:Neutrophile lymphocyte ratio,PLR:Platelet lymphocyte ratio) to historical controls
- Secondary Outcome Measures
Name Time Method Postoperative complications and length of hospital stay Adverse events during neoadjuvant chemotherapy Skeletal muscle mass index,grip strength,6 minute walk test Change in quality of life from the start of chemotherapy to before surgery Completion rate of adjuvant chemotherapy(6 months) Overall survival Recurrence free survival